Future proof your compliance strategy

Leverage cutting-edge technology to provide timely regulatory updates, predictive analytics and automated workflows. Stay ahead of regulatory changes and ensure continuous compliance for sustained success.

Book a demo
Lifescience Banner 1
Lifescience Banner 2

Your Regulatory Solution

Challenge Green Icon

Challenge

Keeping up with frequent regulatory changes, such as FDA updates or EU directives, can lead to compliance gaps and inefficiencies in drug development and clinical trials.

3 Arrows Green Icon
Alerts Icon

Solution

RegAlerts enables you to stay ahead with timely, accurate, and actionable alerts. Receive instant notifications and in-depth analysis to manage drug development, clinical trials, and regulatory submissions proactively.

Explore RegAlerts
Challenge Green Icon

Challenge

Limited access to comprehensive and actionable compliance insights makes data-driven decision-making challenging, impacting R&D, and maintaining regulatory compliance.

3 Arrows Green Icon
Data Driven Excellence Icon

Solution

RegInsights unlocks augmented analytics that drive data-informed decisions for R&D and compliance. Optimized workflows and insights ensure regulatory adherence and research success.

Explore RegInsights
Challenge Green Icon

Challenge

Navigating complex regulatory environments can be difficult due to a lack of reliable and accurate information, increasing risks in drug approvals and market access.

3 Arrows Green Icon
AskRegASK Product Icon

Solution

Ask RegASK delivers precise and reliable answers to regulatory queries. Leverage over 1700 regulatory experts in over 120 countries to navigate complex environments with ease.

Explore Ask RegASK
Challenge Green Icon

Challenge

Integrating multiple compliance tools and processes into a cohesive system is challenging, often leading to inefficiencies and fragmented workflows.

3 Arrows Green Icon
Reggenius Product Icon (2)

Solution

RegGenius integrates multiple AI-Driven capabilities; a GenAI conversational platform, augmented analytics, content summarization and translations. Ensuring efficient management of regulatory submissions, quality compliance, and supply chain operations.

Explore RegGenius

Why RegASK

Why Regask

At RegASK we combine advanced machine learning algorithms with expertise of our regulatory professionals to deliver accurate actionable timely insights.

Leverage RegASK to identify and mitigate regulatory risks with advanced technologies, reducing errors and ensuring accuracy.

RegASK tailors regulatory insights to your specific needs, ensuring relevant and actionable information. Our platform adapts to businesses of all sizes, offering a comprehensive and dynamic approach to compliance management.

RegASK's cutting-edge platform features a powerful task management system that transforms regulatory workflows, empowering you to seamlessly manage every aspect of the regulatory process.

Stay ahead of compliance requirements with RegASK’s timely monitoring, enabling proactive identification of non-compliance issues and generating timely reports.

Cta 2 Strip
“RegASK provides us with customized, timely and actionable regulatory intelligence to ensure compliance with the dynamic global regulatory environment, and drive a competitive advantage for our business. We are pleased with our decision to partner with RegASK.”

Todd Chermak R.Ph., Ph.D.
GSVP and Global Business Head Immunology and Proteomics
CellCarta

Resources

EMA Releases June 2025 PRAC Safety Updates for EU-Autho…
The European Medicines Agency (EMA) has released updated safety signal recommendations from its PRAC committee on June 2, 2025.This update r…
Read more
FDA Launches “Elsa”: Agency-Wide Generative…
On June 2, 2025, the U.S. Food and Drug Administration (FDA) officially launched Elsa, a generative artificial intelligence (AI) tool develo…
Read more
Powering Global Hybrid Clinical Trials: Simplified, Com…
The Challenge A leading global pharmaceutical company was preparing to scale hybrid clinical trials for its Food for Special Medical Purpose…
Read more
MAHA Commission Releases Report on U.S. Childhood Chron…
Presidential Commission Releases Landmark Report on U.S. Childhood Chronic Disease Crisis May 22, 2025 – The Presidential Commission to Ma…
Read more
ANVISA Publishes Preliminary Manual for Brazil’s UDI …
ANVISA Publishes Preliminary Manual for Brazil’s Unique Device Identification (UDI) Database May 28, 2025 – The Brazilian National Healt…
Read more
HHS and FDA Request for Information: Identifying Unnece…
On May 13, 2025, the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) issued a Request for…
Read more